28
Update on shock management Dr. Manal Al Maskati Oct, 2011 - Kuwait

Update on shock management

  • Upload
    edan

  • View
    55

  • Download
    4

Embed Size (px)

DESCRIPTION

Update on shock management. Dr. Manal Al Maskati Oct, 2011 - Kuwait. Objectives. Briefing about pathophysiology of shock. Initial steps of pt’s stabilization. Work-up in A/E. Some important procedures ,which considered beneficial for shock management. - PowerPoint PPT Presentation

Citation preview

Page 1: Update on shock management

Update on shock management

Dr. Manal Al MaskatiOct, 2011 - Kuwait

Page 2: Update on shock management

Objectives Briefing about pathophysiology of shock. Initial steps of pt’s stabilization. Work-up in A/E. Some important procedures ,which

considered beneficial for shock management.

How ?When? and What ? medications are important to know to manage any type of shock.

Page 3: Update on shock management

Pathophysiology Shock inadequate delivery of

substrates and oxygen to meet the metabolic needs of tissues.

Cell anaerobic metabolic pathway accumulation of lactic acid.

Hypoxic-ischemic injury widespread cellular death multiple system organ failure death.

Page 4: Update on shock management

Pathophysiology DO2 (mL O2/min) =

CaO2 (mL O2/L blood) X CO (L/min)

DO2 amount of oxygen delivered to body tissues/ min.

CaO2 oxygen-carrying capacity depends on: Hemoglobin (Hb) content Arterial oxygen saturation

(SaO2). CO cardiac output depends on:

stroke volume (SV) heart rate (HR).

CO = HR (beats/min) X SV (mL/beat)

SV stroke volume depends on: Preload Afterload Contractility

BP = CO X SVR

Page 5: Update on shock management

Treatment ABC Non-invasive monitors Abx in septic shock with empiric coverage

Neonates : combination of ampicillin and gentamicin.

Older infants and children: third-generation cephalosporin,with vancomycin if indicated.

Baseline work-up

Page 6: Update on shock management

Treatment Volume expansion

Children with hypovolemic shock receive appropriate aggressive fluid resuscitation within the 1st hr of resuscitation optimal chance of survival and

recovery. Place 2 large-bore IV catheters or IO access. Administer 20 mL/kg isotonic crystalloid infusion re-

evaluate administer additional 20 mL/kg if needed. If > 2-3 of 20-mL/kg volumes crystalloid given to

patient at risk for hemorrhage packed RBCs. In study of survival in children with septic shock

children received an average 65 mL/kg of volume in 1st hr had statistically increased chance of survival compared with other groups received < 40 mL/kg in 1st hr.

Exception to repetitive volume resuscitation cardiogenic shock.

Page 7: Update on shock management

Work-Up CBC count

Hb oxygen-carrying capacity.

or white cell count septic shock.

Thrombocytopenia bleeding disorder or DIC.

Page 8: Update on shock management

Acid-base status

Shock produces lactic acid metabolic acidosis with anion gap.

Diarrhea leads to direct bicarbonate loss.

Measurement of serum lactate level distinguish bicarbonate loss from lactic acidosis due to shock.

Work-Up

Page 9: Update on shock management

Complete metabolic panel Hypernatremia intravascular volume

contraction hypovolemic shock. serum carbon dioxide metabolic acidosis. Hypovolemia BUN and creatine levels. liver enzymes hypoxic-ischemic damage

to liver.

Work-Up

Page 10: Update on shock management

B-type natriuretic peptide BNP : hormone produced by ventricular

myocytes in response to myocardial wall stress. Plasma BNP levels (adult and pediatric studies)

in sepsis and congestive heart failure with cardiogenic shock.

Elevated levels of BNP myocardial stress, and improvement in cardiac function normalization of BNP levels.

Work-Up

Page 11: Update on shock management

Imaging Studies

Never delay resuscitation of patient in shock

CXR Cardiomegaly in cardiogenic shock. Small heart size in hypovolemic shock . ARDS from pneumonia and sepsis.

Work-Up

Page 12: Update on shock management

Other Tests Near-infrared spectroscopy (NIRS)

Values correlate with venous oxygen saturations noninvasive measurements of increased or decreased tissue oxygen saturation (adequate or inadequate DO2 ).

Cardiac index CO divided by body surface area (BSA) Normal CI is 3.5-5.5 L/min/m2 Cardiac index invasive or

noninvasive measurements (Doppler echocardiography, or classic pulmonary artery catheter).

Work-Up

Page 13: Update on shock management

Procedures Mixed Venous Oxygen Saturation (SvO2) Blood gas from central venous catheter or Swan-

Ganz catheter. In patient with normal SaO2 (90-100%) SvO2

70-80%. Tissues extract 28-33% of oxygen delivered to

them. If oxygen extraction difference > 33% poor

tissue perfusion state of shock. If oxygen extraction difference < 25%

oxygenated blood shunting distributive shock.

Page 14: Update on shock management

Procedures Central venous pressure and pulmonary

capillary wedge pressure Low CVP or PCWP inadequate

intravascular volume. Normal CVP 1-3 cm H2 O.

Pressures > 10 cm H2 O volume overload or poor right-sided heart function

PCWP of 12-18 cm H2o good perfusion.

Page 15: Update on shock management

Medications Dextrose administration often necessary If glucose level low 0.5-1 g/kg IV

Dextrose. Shock with documented hypocalcemia, or

caused by arrhythmias (hyperkalemia, hypermagnesemia, or calcium channel blocker toxicity) calcium therapy.

Recommended dose is 10-20 mg/kg (0.1-0.2 mL/kg of calcium chloride 10%) IV at infusion rate 100 mg/min.

Page 16: Update on shock management

Sodium bicarbonate use in treatment of shock is controversial.

No better effect on Ability to defibrillate DO2

Survival rates in shock and cardiac arrest

Medications

Page 17: Update on shock management

In patients with persistent shock or ongoing bicarbonate loss (eg, severe diarrhea) careful replacement of bicarbonate. HCO3

- (mEq) = Base deficit X patient's weight (in kg) X 0.3

Half of calculated bicarbonate deficit administered initially.

OR 0.5-1 mEq/kg/dose IV infused over 1-2

minutes.

Medications

Page 18: Update on shock management

Vasopressors/inotropic agents Increase myocardial contractility + variable

effects on peripheral vascular resistance Dopamine

o 1st inotrope fluid-refractory septic shock .

o Low dose (2-5 mcg/kg/min IV) vasodilatory effect on end-organ perfusion .

o Intermediate dose (5-10 mcg/kg/min IV) improves myocardial contractility + CO + enhancing conduction.

o Higher dose (10-20 mcg/kg/min IV ) increases peripheral vasoconstriction + BP.

Medications

Page 19: Update on shock management

Dobutamineo Good for cardiogenic shock. o Increases cardiac contractility +

peripheral vasodilation (afterload and improve tissue perfusion).

o Less likely to precipitate ventricular dysrhythmias than epinephrine.

o Dose begins with 5 mcg/kg/min IV , gradually increased to 20 mcg/kg/min IV.

Medications

Page 20: Update on shock management

Epinephrine o For fluid refractory dopamine resistant,

non-vasodilatory (cold) shock. o Increases myocardial contractility +

peripheral vasoconstriction. o Risk of ventricular dysrhythmias +

extremities ischemiao Dose : 0.1 mcg/kg/min IV , titrated

upward according to effect and adverse effects.

o Severe cases 2-3 mcg/kg/min IV or higher.

Medications

Page 21: Update on shock management

Norepinephrine o For fluid-refractory, dopamine-resistant

vasodilatory (warm) shock. o Increases peripheral vasoconstriction

BP.o Best pressor agent increases BP in shock

persists after adequate fluid replacement. o Dose : 0.1 mcg/kg/min IV ,titrated upward

according to effect and adverse effects.

Medications

Page 22: Update on shock management

Phosphodiesterase Enzyme Inhibitor Inamrinone + milrinone

o Useful for shock with adequate intravascular volume, but need increased cardiac contractility and better peripheral perfusion ( compensated shock with poor peripheral perfusion).

o Improve cardiac inotropy + peripheral vasodilation.

o Phosphodiesterase inhibitor used together with catecholamines increase myocardial contractility + reducing systemic vascular resistance and afterload.

Medications

Page 23: Update on shock management

Inamrinone + milrinoneo Inamrinone : loading dose of 0.75 mg/kg

IV over 2-3 minutes followed by continuous IV infusion of 5-10 mcg/kg/min.

o Milrinone : loading dose of 25-50 mcg/kg over 10 minutes, followed by continuous IV infusion of 0.375-0.75 mcg/kg/min.

o Adverse effects: arrhythmias + thrombocytopenia

Medications

Page 24: Update on shock management

Prostaglandin E1o Neonates with shock (large liver, enlarged

cardiac silhouette, or heart murmur) obstructive shock(PDA closure) .

o PDA allow sufficient systemic blood flow to bypass obstructive lesion.

o PGE1 maintains patency of PDA. o Dose 0.05-0.1 mcg/kg/min IV as

continuous infusion.o Adverse effects : fever, apnea, or

hypotension due to vasodilation.

Medications

Page 25: Update on shock management

Corticosteroido Use of corticosteroids in septic shock

controversialo Adrenocortical failure or infarction

(Waterhouse-Friderichsen syndrome) cardiovascular failure + hyporesponsiveness to catecholamines.

o Initiation of stress-dose hydrocortisone (50-100 mg/m2/d IV), may be lifesaving.

o A serum cortisol level drawn prior to first dose of corticosteroids serum cortisol level low replacement doses.

Medications

Page 26: Update on shock management

Corticosteroido Study of adult patients with septic shock

survived 48 hours ,dependent on inotropic agents showed some benefit when treated with supraphysiologic doses of corticosteroids.

o Patients developed adrenal insufficiency 1-2 mg/kg hydrocortisone IV every 6 hours OR 50 mg/kg bolus followed by same amount infused over 24 hours.

o Therapy continued for patients absolute baseline cortisol level < 20 mcg/dL.

Medications

Page 27: Update on shock management

Initial steps of stabilization make tremendous difference in pts survival.

In non-cardiogenic shock fluid fluid fluid.

Early Abx improved survival in septic shock.

Arrange for ICU bed.

Don’t forget the Team-Work management.

Take Home Message

Page 28: Update on shock management

Thank you

Discussion